BioAtla Inc

NASDAQ:BCAB   4:00:00 PM EDT
10.41
+0.56 (+5.68%)
7:50:00 PM EDT: $10.40 -0.01 (-0.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)492.91M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.29 Million
Adjusted EPS-$0.72
See more estimates
10-Day MA$9.31
50-Day MA$7.88
200-Day MA$5.64
See more pivots

BioAtla Inc Stock, NASDAQ:BCAB

11085 Torreyana Road, San Diego, California 92121
United States of America
Phone: +1.858.558.0708
Number of Employees: 56

Description

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.